Medtronic’s MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany

 Medtronic’s MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany

Medtronic’s MiniMed 670G Insulin Pump System Receives Reimbursement for Patients with T1D in Germany

Shots:

  • Medtronic reports that it has secured for its reimbursement for the MiniMed 670G insulin pump system with the German Federal Association of the Statutory Health Insurances (GKV-SV). The reimbursement agreement will be effective from Aug 29, 2019
  • The granted reimbursement will increase the accessibility of Medtronic’s MiniMed 670G Insulin pump system to more patients with type 1 diabetes
  • MiniMed 670G is the only commercially available technology that personalizes the delivery of basal insulin 24hrs. a day based on real-time insulin needs, maximizing Time in Range in patients with T1D

Click here to­ read full press release/ article | Ref: Medtronic | Image: Integrated Diabetes Services

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post